A major medical journal has published research questioning how long patients with a serious heart valve infection need to take antibiotics, with findings that could reshape treatment decisions.
The New England Journal of Medicine (NEJM) has posted findings from the POET II trial, which looked at antibiotic treatment for left-sided infective endocarditis — a bacterial infection of the inner lining of the heart, most often affecting the valves. According to the journal, the current standard of up to six weeks of intravenous antibiotics is based largely on expert opinion rather than clinical trial evidence.
The POET II trial tested what researchers call a response-tailored strategy — adjusting the length of antibiotic treatment based on how individual patients respond, rather than applying a fixed six-week course to everyone. The NEJM has summarised the findings in a Quick Take video.
This matters. Infective endocarditis (IE) is a life-threatening condition, and prolonged hospital stays for intravenous antibiotics carry their own risks, including infection and complications from long-term drip lines.
The NEJM attributed the findings to the POET II research team. No specific patient numbers, outcome figures, or statistical results were included in the @NEJM social media post used as the source for this article; the full published trial data is available in the journal directly.
Anyone concerned about symptoms of infective endocarditis — which can include fever, chills, fatigue, a new or changed heart murmur, or unexplained joint pain — should contact their GP or call NHS 111. In an emergency, call 999. Kent residents seeking further guidance on cardiac services can contact their GP for referral to local providers, including Maidstone and Tunbridge Wells NHS Trust and East Kent Hospitals University NHS Foundation Trust, both of which provide care for patients with infective endocarditis.
Source: @NEJM